Fluidigm Q4 Revenues Fall 8 Percent | GenomeWeb

NEW YORK (GenomeWeb) - Fluidigm announced after the close of the market Thursday that its fourth quarter revenues decreased 8 percent year over year or 4 percent on a constant currency basis.

For the three months ended Dec. 31, the South San Francisco, California-based firm reported total revenues of $30.7 million compared to $33.5 million in the year-ago period, within its preannouncement range of $30 million to $31 million in revenues and beating the Wall Street estimate of $29.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.